Clinical trials
Phase 1 COVID-19 trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
174 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2020 | 60 |
| 2021 | 44 |
| 2022 | 33 |
| 2023 | 13 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 111 |
| Terminated | 30 |
| Withdrawn | 11 |
| Unknown status | 9 |
| Recruiting | 7 |
| Active, not recruiting | 4 |
| Not yet recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 15 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 12 |
| GlaxoSmithKline | 5 |
| ImmunityBio, Inc. | 4 |
| Ampio Pharmaceuticals. Inc. | 3 |
| AstraZeneca | 3 |
| Baylor College of Medicine | 3 |
| Enanta Pharmaceuticals, Inc | 3 |
| ModernaTX, Inc. | 3 |
| Regeneron Pharmaceuticals | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 174 |
| Coronavirus Infections | 30 |
| Virus Diseases | 7 |
| Pneumonia | 6 |
| Post-Acute COVID-19 Syndrome | 5 |
| Respiratory Distress Syndrome | 5 |
| Respiratory Insufficiency | 5 |
| Severe Acute Respiratory Syndrome | 5 |
| Influenza, Human | 4 |
| Neoplasms | 4 |
Trials
Showing 1 to 25 of 174. Each trial links to its page on Pharma Observatory.
74 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.